PNC Financial Services Group
ABEO icon

PNC Financial Services Group’s Abeona Therapeutics ABEO Stock Holding History

PNC Financial Services Group’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.52K Buy
569
+483
+562% +$2.65K ﹤0.01% 4512
2026
Q1 		$385 Buy
86
+81
+1,620% +$405 ﹤0.01% 4968
2025
Q4 		$26 Sell
5
-477
-99% -$2.4K ﹤0.01% 5123
2025
Q3 		$2.54K Buy
+482
New +$3.06K ﹤0.01% 4436

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

PNC Financial Services Group's ABEO Position: Q2 2026 in Review

PNC Financial Services Group increased its Abeona Therapeutics (ABEO) stake by 562% in Q2 2026, buying an estimated $2.65K and bringing the position to 569 shares worth $3.52K. The position accounts for ﹤0.01% of the portfolio, ranked #4512.

PNC Financial Services Group first reported a position in ABEO in Q3 2025 and has held it in 4 quarters since. 126 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • PNC Financial Services Group held 569 shares of Abeona Therapeutics worth $3.52K as of Q2 2026.
  • PNC Financial Services Group bought 483 Abeona Therapeutics shares in Q2 2026, an estimated $2.65K.
  • Abeona Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4512 holding.
  • PNC Financial Services Group first reported a position in Abeona Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 126 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.